RecruitingNCT07558174

SPECTATOR: Perfusion Monitoring Before, During and After Lower Extremity Revascularization With Laser Speckle Contrast Imaging


Sponsor

Leiden University Medical Center

Enrollment

30 participants

Start Date

May 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to evaluate the feasibility of Laser Speckle Contrast Imaging for perioperative perfusion assessment of the lower extremity before, during, and after revascularization.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Laser Speckle Contrast Imaging for people with vascular disease,peripheral. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTLaser Speckle Contrast Imaging

Measurement with LSCI device


Locations(1)

Leiden University Medical Center

Leiden, South Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07558174


Related Trials